The economic burden of cancers attributable to smoking in Korea, 2014

Abstract

INTRODUCTIONAssociations between smoking, cancer and mortality are well established. Although cancer mortality rates have decreased in recent years, the economic burden of smoking-related cancers continues to increase. This study investigates the economic costs of cancers related to smoking in Korea in 2014.METHODSCancer patients were identified through National Health Insurance Services medical claims with ICD-10 cancer codes. We multiplied the costs by the population attributable fraction for each type of cancer and calculated direct and indirect costs, where direct costs comprise direct medical and non-medical costs of inpatients and outpatients, and indirect costs include estimates of future income loss due to premature death, productivity loss during hospitalization and outpatient visits, and job loss.RESULTSIn 2014, there were 79297 smoking-related cancer patients, accounting for 8.47% of all Korean cancer cases for that year. The direct cost of cancers due to smoking was approximately 595 million USD, whereas indirect costs were much higher, at nearly 2.2 billion USD. The average expenditure of a typical patient was 34815 USD. Lung, liver and stomach cancers were most prevalent and represented the most significant share of the economic burden, whereas the largest per-patient spending was for pancreatic, liver, and lung cancers. Lung, liver and stomach cancers had the highest economic impact on men, while lung, liver and ovarian cancers had the most significant economic impact on women.CONCLUSIONSIt is imperative that more stringent steps be taken to reduce the huge economic burden of cancers linked to smoking.ABBREVIATIONSIARC: International Agency for Research on Cancer, PAF: population attributable fraction, NHIS: National Health Insurance Services, ICD-10: International Statistical Classification of Diseases and Related Health Problem 10th Revision, GDP: Gross Domestic Product, DALYs: Disability-Adjusted-Life-Years, WHO: World Health Organization, FCTC: Framework Convention on Tobacco Control.

The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective

“…Regarding the method for indirect cost estimation, our approach was similar to a previous study in South Korea in 2019. That study found that the indirect cost was approximately 77.91% of the total cost, and future income lost accounted for the largest percentage of the cost components [32]. In Iran, researchers found that it accounted for 55% of the total cost (not including productivity loss or job loss) [19].…”

Vitamin D supplementation to the older adult population in Germany has the cost‐saving potential of preventing almost 30 000 cancer deaths per year

“…A typical threshold for cost-effectiveness of interventions is $50 000 (approximately €46 000) per quality-adjusted life-year, but this threshold has been criticized as being too low [18]. Novel cancer treatments are often considered cost-effective despite much less favorable ratios [19][20][21][22][23][24][25] (see Table S3 for examples). Although estimates for cancer mortality reduction did not consider tumor stage, site, molecular subtypes, etc., our results suggest that daily vitamin D supplementation in the German population aged 50 years and older for reducing cancer mortality would be overall cost-saving, or at least highly cost-effective.…”

Economic burden of smoking attributed illnesses in Pakistan

“…The GDP lost i.e. 0.41% of Pakistan due to smoking attributed illnesses is higher than reported from Iran (0.26%) 16 , Korea (0.2%) 17 and Sri Lanka (0.15%) 18 . But it is less than Thailand and Uganda where the smoking attributed burden accounts for 0.7% and 0.5% of the country GDP respectively 19 20 .…”